2021-08-02 | Sale | Kiora Pharmaceuticals, Inc. KPRX | 10 percent owner | | $2.40 | $463,046 | -69.8% | |
2021-07-30 | Sale | Kiora Pharmaceuticals, Inc. KPRX | 10 percent owner | | $2.69 | $183,562 | -70.83% | |
2021-07-29 | Sale | Kiora Pharmaceuticals, Inc. KPRX | | | $3.00 | $1.2M | -74.57% | |
2021-07-28 | Sale | Kiora Pharmaceuticals, Inc. KPRX | | | $3.28 | $1.23M | -76.79% | |
2021-07-27 | Sale | Kiora Pharmaceuticals, Inc. KPRX | | | $5.09 | $12.11M | -79.9% | |
2021-06-18 | Sale | ReShape Lifesciences Inc. RSLS | 10 percent owner | | $5.48 | $3.76M | -65.17% | |
2021-06-17 | Sale | ReShape Lifesciences Inc. RSLS | 10 percent owner | | $6.27 | $6.93M | -67.74% | |
2021-06-16 | Sale | ReShape Lifesciences Inc. RSLS | 10 percent owner | | $6.92 | $3.54M | -69.84% | |
2021-01-06 | Purchase | Kiora Pharmaceuticals, Inc. KPRX | | | $5.22 | $8M | -32.02% | |
2020-12-11 | Purchase | Aytu BioPharma, Inc. AYTU | director | | $6.00 | $8M | -17.04% | |
2020-09-30 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.13 | $715 | -41.89% | |
2020-09-29 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.14 | $700 | -37.19% | |
2020-09-28 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.13 | $646 | -37.04% | |
2020-09-24 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.13 | $4,973 | -36.88% | |
2020-09-23 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.14 | $7,000 | -41.36% | |
2020-09-22 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.15 | $2,550 | -45.27% | |
2020-09-21 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.15 | $15,000 | -45.2% | |
2020-09-16 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.16 | $20,000 | -48.44% | |
2020-09-15 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.16 | $13,133 | -51.41% | |
2020-09-14 | Sale | Cyclo Therapeutics, Inc. CYTH | 10 percent owner | | $0.17 | $22,100 | -51.32% | |